Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FD786
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,711
Award facts
- Contract value 100% obligated
- $34,711.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,711.05 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets in quantities of 30-count units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 7, 2025. The award was made on November 6, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. XELJANZ XR is a branded pharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions, representing part of the company's broader pharmaceutical distribution portfolio supporting federal medical procurement.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which holds a ceiling value of $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has consistently demonstrated capability to fulfill open competition federal medical procurement requirements across multiple therapeutic domains through firm fixed-price delivery orders.
Quick answers
Who was awarded contract SPE2DR26FD786?
SPE2DR26FD786 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FD786 worth?
The government has obligated $34,711 on SPE2DR26FD786.
Is contract SPE2DR26FD786 an order under another contract?
Yes. SPE2DR26FD786 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FD786 competed?
The extent of competition for SPE2DR26FD786 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award